A002 A tyrosine PEG-micelle magnetic resonance contrast agent for the detection of lipid rich areas in the atherosclerotic plaque
Anne Beilvert(LFB (France)), Zahi A. Fayad(Icahn School of Medicine at Mount Sinai), Willem J. M. Mulder(Radboud University Nijmegen), David P. Cormode(University of Pennsylvania), Venkatesh Mani(Icahn School of Medicine at Mount Sinai), Didier Letourneur(Université Paris Cité), Karen Briley‐Sæbø(Icahn School of Medicine at Mount Sinai), Jean‐François Toussaint(Université Paris Cité), Frédéric Chaubet(Centre National de la Recherche Scientifique)
Cited by 0
Related Papers
CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV)
|Radiology|2020|2.9k
Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection
|Radiology|2020|2.8k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k
Defining trained immunity and its role in health and disease
|Nature reviews. Immunology|2020|2.5k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.3k